Advancement in Medical Simulation Technology Unveiled by Simulab Corporation

Simulab Corporation, a leading company in the medical simulation industry based in Seattle, WA, is pleased to announce the launch of its latest technological innovation – SimuSkin™. This groundbreaking development represents a significant achievement for the company, demonstrating its ongoing commitment to enhancing the realism and effectiveness of healthcare simulation in medical education.

SimuSkin™ is the culmination of extensive research and development by Simulab, meticulously crafted to faithfully replicate human tissue in terms of appearance, texture, tactile response, and surgical feel. This advancement not only establishes a new standard for realism in medical simulation but also ensures durability and material integrity, setting a new benchmark for medical training tools.

With immediate effect, SimuSkin™ will be integrated into all soft tissue components and consumables of Simulab’s TraumaMan™ System, underscoring the company’s dedication to providing medical professionals with the most advanced training resources available.

Simulab Corporation cordially invites members of the press to experience SimuSkin™ firsthand at the upcoming Society for Simulation in Healthcare’s International Meeting, IMSH 2024 in San Diego, which will take place at the San Diego Convention Center from January 21-23. This event presents a unique opportunity to explore the distinctive features of the product and participate in discussions regarding its impact on medical training and patient care.

For over 30 years, Simulab Corporation has been a trailblazer in soft-tissue simulation technology, with a mission to enhance patient outcomes by offering healthcare professionals realistic and high-quality training tools. Through unwavering commitment to innovation and quality, the company has solidified its position as a key player in the healthcare simulation industry, consistently pushing the boundaries of what is achievable in medical education and healthcare simulation.

For further information, please contact:
Christie Angino
Director of Marketing
Simulab Corporation
[email protected]
206-498-1667

SOURCE: Simulab Corporation
To view the original press release, visit newswire.com.